Table 3. Factors associated with lymph node involvement.
| Seminomas | NSGCT | |||||
|---|---|---|---|---|---|---|
| Univariate | Multivariate | Univariate | Multivariate | |||
| p-value | p-value | OR (95% CI) | p-value | p-value | OR (95% CI) | |
| Size >4 cm | 0.576 | 0.580 | 0.426 | 0.893 | ||
| T staging | 0.058 | 0.230 | <0.01 | 0.025 | 6.32 (1.53–11.81) | |
| S staging | 0.404 | 0.687 | <0.01 | 0.104 | ||
| NLR ≥3.0 | <0.01 | 0.031 | 2.91 (1.67–5.83) | <0.01 | 0.038 | 4.12 (1.26–6.51) |
| Metastatic disease | <0.01 | <0.01 | 8.95 (6.12–15.87) | <0.01 | 0.018 | 10.24 (7.83–16.55) |
NSGCT, non-seminomatous germ cell tumour; OR, odds ratio; CI, confidence interval; NLR, neutrophil-to-lymphocyte ratio.